Evidence map›Paper›PMID 31573976›Full record

Observational studyJCI insight2019

Haptoglobin-2 variant increases susceptibility to acute respiratory distress syndrome during sepsis.

V Eric Kerchberger, Julie A Bastarache, Ciara M Shaver, Hiromasa Nagata, J Brennan McNeil, Stuart R Landstreet, Nathan D Putz, Wen-Kuang Yu, Jordan Jesse, Nancy E Wickersham and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. American journal of respiratory and critical care medicine · 2024
    Observational
  17. Article
  18. Review
  19. Liraglutide pretreatment attenuates sepsis-induced acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

V Eric KerchbergerDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Julie A BastaracheDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Ciara M ShaverDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Hiromasa NagataDepartment of Anesthesiology, Keio University School of Medicine, Tokyo, Japan.
J Brennan McNeilDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Stuart R LandstreetDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Nathan D PutzDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Wen-Kuang YuDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Jordan JesseDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Nancy E WickershamDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Tatiana N SidorovaDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
David R JanzSection of Pulmonary and Critical Care Medicine, Louisiana State University School of Medicine, New Orleans, Louisiana, USA.
Chirag R ParikhDivision of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Edward D SiewDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Lorraine B WareDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine.
Pulmonary and Allergy Associates · USJohns Hopkins University · USKeio University · JPLouisiana State University · USNational Yang Ming Chiao Tung University · TWVanderbilt University Medical Center · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Vanderbilt Biomedical Informatics Training ProgramT15LM007450 · NLM · VANDERBILT UNIVERSITY · PI Jessica S. Ancker, Bradley A. Malin · 2002 to 2026
$19.7M
TIPS: Training in Perioperative ScienceT32GM108554 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Eric J Delpire · 2014 to 2026
$3.7M
Targeting cell-free hemoglobin in sepsis to reduce lung microvascular permeability: mechanistic and translational studiesR01HL135849 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BASTARACHE, JULIE ANNE, WARE, LORRAINE B · 2017 to 2020
$2.2M
Midcareer Investigator Award in Patient-Oriented Research in Acute Lung InjuryK24HL103836 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WARE, LORRAINE B · 2010 to 2020
$1.6M
Mechanisms of airspace inflammation caused by cell-free hemoglobin during ARDSK08HL136888 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHAVER, CIARA M · 2017 to 2021
$858k
Leica Bond RXS10OD023475 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOYD, KELLI L. · 2018 to 2018
$213k
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002243NHLBI NIH HHS K08 HL136888NHLBI NIH HHS K24 HL103836NHLBI NIH HHS R01 HL135849NIGMS NIH HHS T32 GM108554NIH HHS S10 OD023475NLM NIH HHS T15 LM007450
6 · The paper itself

Abstract

Acute respiratory distress syndrome (ARDS) is an inflammatory lung disorder that frequently complicates critical illness and commonly occurs in sepsis. Although numerous clinical and environmental risk factors exist, not all patients with risk factors develop ARDS, raising the possibility of genetic underpinnings for ARDS susceptibility. We have previously reported that circulating cell-free hemoglobin (CFH) is elevated during sepsis, and higher levels predict worse outcomes. Excess CFH is rapidly scavenged by haptoglobin (Hp). A common HP genetic variant, HP2, is unique to humans and is common in many populations worldwide. HP2 haptoglobin has reduced ability to inhibit CFH-mediated inflammation and oxidative stress compared with the alternative HP1. We hypothesized that HP2 increases ARDS susceptibility during sepsis when plasma CFH levels are elevated. In a murine model of sepsis with elevated CFH, transgenic mice homozygous for Hp2 had increased lung inflammation, pulmonary vascular permeability, lung apoptosis, and mortality compared with wild-type mice. We then tested the clinical relevance of our findings in 496 septic critically ill adults, finding that HP2 increased ARDS susceptibility after controlling for clinical risk factors and plasma CFH. These observations identify HP2 as a potentially novel genetic ARDS risk factor during sepsis and may have important implications in the study and treatment of ARDS.

Indexed as

AdultAnimalsApoptosisCapillary PermeabilityGenetic Predisposition to DiseaseHaptoglobinsHumansLungMiceMice, TransgenicProspective StudiesRespiratory Distress SyndromeSepsisSurvival AnalysisHaptoglobinsGeneticsGenetic variationMouse modelsPulmonology

Identifiers

PMID31573976
PMCPMC6948757
OpenAlexW2977363205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.